A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

This study will evaluate the efficacy and safety of ALKS 5461.

Phase 3

Alkermes, Inc.